CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2024 | Mar. 31, 2023 | Dec. 31, 2023 |
Operating activities: | | | |
Net income | $ 88,905 | $ 112,246 | |
Adjustments to reconcile net income to net cash provided by operating activities: | | | |
Depreciation and amortization | 91,218 | 87,741 | |
Accretion of debt premium and discount, net | (728) | (716) | |
Deferred financing cost amortization | 1,796 | 1,755 | |
Accretion of above- and below-market leases, net | (2,408) | (3,389) | |
Tenant inducement amortization and other | 731 | 804 | |
Impairment of real estate assets | 0 | 1,100 | |
Gain on sale of real estate assets | (15,142) | (48,468) | |
Equity based compensation | 3,359 | 4,191 | |
Changes in operating assets and liabilities: | | | |
Receivables, net | 28,639 | 15,578 | |
Deferred charges and prepaid expenses | (9,020) | (11,815) | |
Other assets | (1,222) | (215) | |
Accounts payable, accrued expenses and other liabilities | (57,612) | (23,758) | |
Net cash provided by operating activities | 128,516 | 135,054 | |
Investing activities: | | | |
Improvements to and investments in real estate assets | (76,861) | (72,376) | |
Proceeds from sales of real estate assets | 67,237 | 119,659 | |
Purchase of marketable securities | (4,366) | (6,162) | |
Proceeds from sale of marketable securities | 4,811 | 7,364 | |
Net cash provided by (used in) investing activities | (9,179) | 48,485 | |
Financing activities: | | | |
Repayment of borrowings under unsecured revolving credit facility | (98,500) | (195,000) | |
Proceeds from borrowings under unsecured revolving credit facility | 80,000 | 117,000 | |
Proceeds from unsecured notes | 399,264 | 0 | |
Deferred financing and debt extinguishment costs | (3,766) | (60) | |
Distributions to common stockholders | (83,866) | (80,080) | |
Repurchases of common shares in conjunction with equity award plans | (12,962) | (11,229) | |
Net cash provided by (used in) financing activities | 280,170 | (169,369) | |
Net change in cash, cash equivalents and restricted cash | 399,507 | 14,170 | |
Cash, cash equivalents and restricted cash at beginning of period | 18,904 | 21,259 | $ 21,259 |
Cash, cash equivalents and restricted cash at end of period | 418,411 | 35,429 | 18,904 |
Reconciliation to consolidated balance sheets: | | | |
Cash and cash equivalents | 407,105 | 3,430 | 866 |
Restricted cash | 11,306 | 31,999 | 18,038 |
Cash, cash equivalents and restricted cash at end of period | 418,411 | 35,429 | 18,904 |
Supplemental disclosure of cash flow information: | | | |
Cash paid for interest, net of amount capitalized of $920 and $949 | 49,384 | 50,250 | |
Brixmor Operating Partnership LP | | | |
Operating activities: | | | |
Net income | 88,905 | 112,246 | |
Adjustments to reconcile net income to net cash provided by operating activities: | | | |
Depreciation and amortization | 91,218 | 87,741 | |
Accretion of debt premium and discount, net | (728) | (716) | |
Deferred financing cost amortization | 1,796 | 1,755 | |
Accretion of above- and below-market leases, net | (2,408) | (3,389) | |
Tenant inducement amortization and other | 731 | 804 | |
Impairment of real estate assets | 0 | 1,100 | |
Gain on sale of real estate assets | (15,142) | (48,468) | |
Equity based compensation | 3,359 | 4,191 | |
Changes in operating assets and liabilities: | | | |
Receivables, net | 28,639 | 15,578 | |
Deferred charges and prepaid expenses | (9,020) | (11,815) | |
Other assets | (1,222) | (215) | |
Accounts payable, accrued expenses and other liabilities | (57,612) | (23,758) | |
Net cash provided by operating activities | 128,516 | 135,054 | |
Investing activities: | | | |
Improvements to and investments in real estate assets | (76,861) | (72,376) | |
Proceeds from sales of real estate assets | 67,237 | 119,659 | |
Purchase of marketable securities | (4,366) | (6,162) | |
Proceeds from sale of marketable securities | 4,811 | 7,364 | |
Net cash provided by (used in) investing activities | (9,179) | 48,485 | |
Financing activities: | | | |
Repayment of borrowings under unsecured revolving credit facility | (98,500) | (195,000) | |
Proceeds from borrowings under unsecured revolving credit facility | 80,000 | 117,000 | |
Proceeds from unsecured notes | 399,264 | 0 | |
Deferred financing and debt extinguishment costs | (3,766) | (60) | |
Partner distributions and repurchases of OP Units | (97,423) | (90,382) | |
Net cash provided by (used in) financing activities | 279,575 | (168,442) | |
Net change in cash, cash equivalents and restricted cash | 398,912 | 15,097 | |
Cash, cash equivalents and restricted cash at beginning of period | 18,904 | 20,332 | 20,332 |
Cash, cash equivalents and restricted cash at end of period | 417,816 | 35,429 | 18,904 |
Reconciliation to consolidated balance sheets: | | | |
Cash and cash equivalents | 406,510 | 3,430 | 866 |
Restricted cash | 11,306 | 31,999 | 18,038 |
Cash, cash equivalents and restricted cash at end of period | 417,816 | 35,429 | $ 18,904 |
Supplemental disclosure of cash flow information: | | | |
Cash paid for interest, net of amount capitalized of $920 and $949 | $ 49,384 | $ 50,250 | |